Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 - Growth, Business Opportunities, Share Value, Key Insights and Size Estimation by 2031

New York, Global Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 report from Global Insight Services is the single authoritative source of intelligence on Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2022 here: https://www.globalinsightservices.com/reports/non-alcoholic-steatohepatitis-nash-drug-pipeline-landscape-2022/

Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.

NASH is most common in patients who are overweight or obese and other risk factors include diabetes, high cholesterol, high triglycerides, poor diet, metabolic syndrome, polycystic ova*ry syndrome, sleep apnea, underactive thyroid (hypothyroidism).

The most common symptoms of moderate NASH include weakness, fatigue, loss of appetite, unexplained weight loss. Other advanced symptoms include yellowing of skin, bruising and bleeding, swelling of legs and feet (edema), enlarged liver or enlarged spleen, enlarged, spider-like blood vessels under your skin.

Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS31004/

Diagnosis of NASH include blood tests, imaging tests (abdominal ultrasound and CT scan), liver stiffness tests (Fibroscan and magnetic resonance elastography) and liver biopsy.

NASH has no specific medical treatments, taking some steps can help prevent further damage like maintaining a moderate weight, and if this involves losing weight, healthy diet with low amounts of processed foods and fats, limiting or avoiding alcohol. The treatment may include medications and possibly surgery. Patients with NASH who develop liver cancer or liver failure may require a transplant.

There are currently several clinical trials underway for potential treatments for NASH. These include trials testing medications that target specific aspects of the disease, such as inflammation or insulin resistance, as well as more general trials testing treatments that aim to improve overall liver function. Many of these trials are still in the early stages, but some have already shown promising results.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31004/

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS31004/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.